Botulinum toxin treatment for blepharospasm associated with myasthenia gravis
Identifieur interne : 002F84 ( Main/Exploration ); précédent : 002F83; suivant : 002F85Botulinum toxin treatment for blepharospasm associated with myasthenia gravis
Auteurs : Kenju Hara [Japon] ; Akiko Matsuda [Japon] ; Yuko Kitsukawa [Japon] ; Keiko Tanaka [Japon] ; Masatoyo Nishizawa [Japon] ; Asako Tagawa [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2007-07-15.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anti-Dyskinesia Agents, Botulinum Toxins.
- complications : Myasthenia Gravis.
- drug therapy : Blepharospasm, Myasthenia Gravis.
- etiology : Blepharospasm.
- methods : Electromyography.
- Adult, Female, Humans.
Url:
DOI: 10.1002/mds.21558
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004151
- to stream Istex, to step Curation: 004151
- to stream Istex, to step Checkpoint: 001A92
- to stream PubMed, to step Corpus: 002745
- to stream PubMed, to step Curation: 002745
- to stream PubMed, to step Checkpoint: 002941
- to stream Ncbi, to step Merge: 001B94
- to stream Ncbi, to step Curation: 001B94
- to stream Ncbi, to step Checkpoint: 001B94
- to stream Main, to step Merge: 003F06
- to stream Main, to step Curation: 002F84
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title><author><name sortKey="Hara, Kenju" sort="Hara, Kenju" uniqKey="Hara K" first="Kenju" last="Hara">Kenju Hara</name></author><author><name sortKey="Matsuda, Akiko" sort="Matsuda, Akiko" uniqKey="Matsuda A" first="Akiko" last="Matsuda">Akiko Matsuda</name></author><author><name sortKey="Kitsukawa, Yuko" sort="Kitsukawa, Yuko" uniqKey="Kitsukawa Y" first="Yuko" last="Kitsukawa">Yuko Kitsukawa</name></author><author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name></author><author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name></author><author><name sortKey="Tagawa, Asako" sort="Tagawa, Asako" uniqKey="Tagawa A" first="Asako" last="Tagawa">Asako Tagawa</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A4AD59E032966B2F4C050C5074E3FCF14C77C650</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/mds.21558</idno><idno type="url">https://api.istex.fr/document/A4AD59E032966B2F4C050C5074E3FCF14C77C650/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004151</idno><idno type="wicri:Area/Istex/Curation">004151</idno><idno type="wicri:Area/Istex/Checkpoint">001A92</idno><idno type="wicri:doubleKey">0885-3185:2007:Hara K:botulinum:toxin:treatment</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:17486596</idno><idno type="wicri:Area/PubMed/Corpus">002745</idno><idno type="wicri:Area/PubMed/Curation">002745</idno><idno type="wicri:Area/PubMed/Checkpoint">002941</idno><idno type="wicri:Area/Ncbi/Merge">001B94</idno><idno type="wicri:Area/Ncbi/Curation">001B94</idno><idno type="wicri:Area/Ncbi/Checkpoint">001B94</idno><idno type="wicri:Area/Main/Merge">003F06</idno><idno type="wicri:Area/Main/Curation">002F84</idno><idno type="wicri:Area/Main/Exploration">002F84</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis</title><author><name sortKey="Hara, Kenju" sort="Hara, Kenju" uniqKey="Hara K" first="Kenju" last="Hara">Kenju Hara</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University</wicri:regionArea><wicri:noRegion>Niigata University</wicri:noRegion></affiliation></author><author><name sortKey="Matsuda, Akiko" sort="Matsuda, Akiko" uniqKey="Matsuda A" first="Akiko" last="Matsuda">Akiko Matsuda</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University</wicri:regionArea><wicri:noRegion>Niigata University</wicri:noRegion></affiliation></author><author><name sortKey="Kitsukawa, Yuko" sort="Kitsukawa, Yuko" uniqKey="Kitsukawa Y" first="Yuko" last="Kitsukawa">Yuko Kitsukawa</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University</wicri:regionArea><wicri:noRegion>Niigata University</wicri:noRegion></affiliation></author><author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University</wicri:regionArea><wicri:noRegion>Niigata University</wicri:noRegion></affiliation></author><author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name><affiliation wicri:level="1"><country wicri:rule="url">Japon</country></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University</wicri:regionArea><wicri:noRegion>Niigata University</wicri:noRegion></affiliation></author><author><name sortKey="Tagawa, Asako" sort="Tagawa, Asako" uniqKey="Tagawa A" first="Asako" last="Tagawa">Asako Tagawa</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Immunology, National Institute of Neuroscience, NCNP</wicri:regionArea><wicri:noRegion>NCNP</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-07-15">2007-07-15</date><biblScope unit="vol">22</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1363">1363</biblScope><biblScope unit="page" to="1364">1364</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A4AD59E032966B2F4C050C5074E3FCF14C77C650</idno><idno type="DOI">10.1002/mds.21558</idno><idno type="ArticleID">MDS21558</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-Dyskinesia Agents (therapeutic use)</term><term>Blepharospasm (drug therapy)</term><term>Blepharospasm (etiology)</term><term>Botulinum Toxins (therapeutic use)</term><term>Electromyography (methods)</term><term>Female</term><term>Humans</term><term>Myasthenia Gravis (complications)</term><term>Myasthenia Gravis (drug therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Dyskinesia Agents</term><term>Botulinum Toxins</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Myasthenia Gravis</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Blepharospasm</term><term>Myasthenia Gravis</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Blepharospasm</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Electromyography</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Japon</li></country></list><tree><country name="Japon"><noRegion><name sortKey="Hara, Kenju" sort="Hara, Kenju" uniqKey="Hara K" first="Kenju" last="Hara">Kenju Hara</name></noRegion><name sortKey="Kitsukawa, Yuko" sort="Kitsukawa, Yuko" uniqKey="Kitsukawa Y" first="Yuko" last="Kitsukawa">Yuko Kitsukawa</name><name sortKey="Matsuda, Akiko" sort="Matsuda, Akiko" uniqKey="Matsuda A" first="Akiko" last="Matsuda">Akiko Matsuda</name><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name><name sortKey="Tagawa, Asako" sort="Tagawa, Asako" uniqKey="Tagawa A" first="Asako" last="Tagawa">Asako Tagawa</name><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F84 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F84 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A4AD59E032966B2F4C050C5074E3FCF14C77C650
|texte= Botulinum toxin treatment for blepharospasm associated with myasthenia gravis
}}
| This area was generated with Dilib version V0.6.23. |  |